Millennium Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-250,925
| Closed | -$3.12M | – | 4125 |
|
|
2016
Q4 | $3.12M | Buy |
+250,925
| New | +$3.02M | 0.01% | 1633 |
|
|
2016
Q3 | – | Sell |
-256,117
| Closed | -$1.89M | – | 3847 |
|
|
2016
Q2 | $1.89M | Sell |
256,117
-37,115
| -13% | -$278K | ﹤0.01% | 1813 |
|
|
2016
Q1 | $1.87M | Buy |
293,232
+15,598
| +6% | +$87.4K | ﹤0.01% | 1811 |
|
|
2015
Q4 | $1.74M | Sell |
277,634
-194,614
| -41% | -$1.28M | ﹤0.01% | 2016 |
|
|
2015
Q3 | $2.76M | Sell |
472,248
-201,005
| -30% | -$1.55M | 0.01% | 1705 |
|
|
2015
Q2 | $5.57M | Sell |
673,253
-971,700
| -59% | -$8.59M | 0.01% | 1333 |
|
|
2015
Q1 | $13.6M | Buy |
1,644,953
+1,502,359
| +1,054% | +$11.1M | 0.03% | 866 |
|
|
2014
Q4 | $980K | Sell |
142,594
-1,420,635
| -91% | -$8.89M | ﹤0.01% | 2500 |
|
|
2014
Q3 | $8.44M | Buy |
1,563,229
+1,426,429
| +1,043% | +$8.33M | 0.02% | 959 |
|
|
2014
Q2 | $871K | Sell |
136,800
-113,800
| -45% | -$783K | ﹤0.01% | 2279 |
|
|
2014
Q1 | $2.02M | Sell |
250,600
-1,216,184
| -83% | -$9.47M | 0.01% | 1771 |
|
|
2013
Q4 | $10M | Buy |
1,466,784
+784,015
| +115% | +$4.23M | 0.03% | 716 |
|
|
2013
Q3 | $12.6M | Buy |
682,769
+627,501
| +1,135% | +$12.2M | 0.04% | 577 |
|
|
2013
Q2 | $967K | Buy |
+55,268
| New | +$980K | ﹤0.01% | 1978 |
|
Other funds holding ARIA
Millennium Management's ARIA Position: Q1 2017 in Review
Millennium Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 250,925 shares — an estimated $3.12M sold.
Millennium Management first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $13.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Millennium Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Millennium Management sold 250,925 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.12M.
- Millennium Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- Millennium Management's Ariad Pharmaceuticals Inc position peaked at $13.6M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.